- Home
- SOHO vs ABVC Comparison
SOHO vs ABVC Comparison
Compare SOHO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- ABVC
- Stock Information
- Founded
- SOHO 2004
- ABVC 2015
- Country
- SOHO United States
- ABVC United States
- Employees
- SOHO N/A
- ABVC N/A
- Industry
- SOHO Real Estate Investment Trusts
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- ABVC Health Care
- Exchange
- SOHO Nasdaq
- ABVC Nasdaq
- Market Cap
- SOHO 16.3M
- ABVC 16.7M
- IPO Year
- SOHO 2004
- ABVC N/A
- Fundamental
- Price
- SOHO $0.67
- ABVC $0.91
- Analyst Decision
- SOHO Hold
- ABVC
- Analyst Count
- SOHO 1
- ABVC 0
- Target Price
- SOHO $1.50
- ABVC N/A
- AVG Volume (30 Days)
- SOHO 48.9K
- ABVC 290.8K
- Earning Date
- SOHO 05-13-2025
- ABVC 05-16-2025
- Dividend Yield
- SOHO N/A
- ABVC N/A
- EPS Growth
- SOHO N/A
- ABVC N/A
- EPS
- SOHO N/A
- ABVC N/A
- Revenue
- SOHO $181,894,287.00
- ABVC $509,788.00
- Revenue This Year
- SOHO $12.99
- ABVC N/A
- Revenue Next Year
- SOHO N/A
- ABVC N/A
- P/E Ratio
- SOHO N/A
- ABVC N/A
- Revenue Growth
- SOHO 4.77
- ABVC N/A
- 52 Week Low
- SOHO $0.63
- ABVC $0.40
- 52 Week High
- SOHO $1.54
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- SOHO 30.01
- ABVC 56.56
- Support Level
- SOHO $0.63
- ABVC $0.65
- Resistance Level
- SOHO $0.73
- ABVC $1.40
- Average True Range (ATR)
- SOHO 0.04
- ABVC 0.11
- MACD
- SOHO -0.01
- ABVC 0.04
- Stochastic Oscillator
- SOHO 21.11
- ABVC 38.54
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.